FDA-approved epilepsy drug may help reverse osteoarthritis damage
60-Word AI Digest
Researchers at Yale have identified a promising new approach to osteoarthritis that could do more than simply ease pain. The epilepsy drug lacosamide appears to block a protein involved in both pain signaling and cartilage destruction, helping damaged joints shift back toward repair in preclinical studies.
Key Takeaways
- Researchers at Yale have identified a promising new approach to osteoarthritis that could do more than simply ease pain.
- The epilepsy drug lacosamide appears to block a protein involved in both pain signaling and cartilage destruction, helping damaged joints shift back toward repair in preclinical studies.
- Full details and original dispatch available below.
Researchers at Yale have identified a promising new approach to osteoarthritis that could do more than simply ease pain. The epilepsy drug lacosamide appears to block a protein involved in both pain signaling and cartilage destruction, helping damaged joints shift back toward repair in preclinical studies.
Original Publisher Attribution
This summary was curated from ScienceDaily.